The majority of independent community pharmacists are interested in incorporating personalized medicine services into their practices, but they require further education before this is possible.
Onco360, one of the nation’s largest independent providers of oncology pharmacy services, on Monday announced that Paul Jardina was named president and CEO.
Burmans, an independent community pharmacy, was announced as a winner of the Patient Safety Award at the annual Innovation Awards presented by Philadelphia Business Journal and UnitedHealthcare.
Emdeon, a provider of healthcare revenue and payment cycle management and clinical information exchange solutions, on Monday announced the completion of the transition from CaparioOne to the Emdeon One brand, and the addition of a new Advanced Denials Management service to be integrated within the Emdeon One portal.
Rx Response moved to alert status in response to the concern about Ebola in the United States.
In the wake of an Oct. 21 blogpost on Health Affairs, “The $500 Billion Medicare Slowdown: A Story About Part D,” Ralph Neas, president and CEO of the Generic Pharmacuetical Association, issued the following statement.
Pfizer on Thursday announced that the U.S. District Court for the District of Delaware upheld its basic patent and the L-malate salt patent covering Sutent (sunitinib malate) capsules.
The U.S. healthcare system must address the problem of patients not picking up newly-prescribed medicines, according to a NEHI white paper.
The Center for Healthcare Supply Chain Research and the American Association of Colleges of Pharmacy are partnering to provide the nation’s schools of pharmacy a supply chain educational tool surrounding the distribution of specialty pharmaceuticals.
GlaxoSmithKline expects to have its Ebola vaccine available by year's end.